151 related articles for article (PubMed ID: 2480428)
1. Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center.
Cariati E; Brizzi L; Periti E
J Nucl Med Allied Sci; 1989; 33(3 Suppl):72-6. PubMed ID: 2480428
[TBL] [Abstract][Full Text] [Related]
2. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
3. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
Aitken DA; Crossley JA
Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of maternal serum alpha-fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.
Brizzi L; Cariati E; Periti E; Nannini R; Torricelli F; Cappelli G; Gheri G
J Nucl Med Allied Sci; 1989; 33(3 Suppl):85-8. PubMed ID: 2480431
[TBL] [Abstract][Full Text] [Related]
5. Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus.
Kramer RL; Yaron Y; O'Brien JE; Critchfield G; Ayoub M; Johnson MP; Qualls CR; Evans MI
Am J Med Genet; 1998 Jan; 75(2):176-8. PubMed ID: 9450880
[TBL] [Abstract][Full Text] [Related]
6. [Unusual behavior of serum markers in risk evaluation for trisomy 21].
Guibaud S; Boisson C; Chambon V; Simplot A
Ann Biol Clin (Paris); 1998; 56(4):439-44. PubMed ID: 9754279
[TBL] [Abstract][Full Text] [Related]
7. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
8. [Maternal serum alpha-fetoprotein as a screening test for fetal Down syndrome].
Bessho T; Kanazawa R; Shiotani T; Mitsuo M; Koyama K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Mar; 47(3):237-43. PubMed ID: 7535328
[TBL] [Abstract][Full Text] [Related]
9. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
[TBL] [Abstract][Full Text] [Related]
10. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].
Thix J
Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823
[TBL] [Abstract][Full Text] [Related]
11. Maternal serum alpha-fetoprotein screening: benefits, risks, and costs.
Campbell TL
J Fam Pract; 1987 Nov; 25(5):461-7. PubMed ID: 2445897
[TBL] [Abstract][Full Text] [Related]
12. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
[TBL] [Abstract][Full Text] [Related]
13. First-year results of routine alpha-fetoprotein testing on prenatal patients in a family practice.
Weiss BD
J Fam Pract; 1988 Mar; 26(3):273-80. PubMed ID: 2450166
[TBL] [Abstract][Full Text] [Related]
14. Prenatal diagnosis policy without routine amniocentesis in pregnancies with a positive family history for neural tube defects.
Papp Z; Tóth Z; Török O; Szabó M
Am J Med Genet; 1987 Jan; 26(1):103-10. PubMed ID: 2433941
[TBL] [Abstract][Full Text] [Related]
15. Risk prediction for Down's syndrome in young pregnant women using maternal serum biomarkers: determination of cut-off risk from receiver operating characteristic curve analysis.
Hwa HL; Ko TM; Hsieh FJ; Yen MF; Chou KP; Chen TH
J Eval Clin Pract; 2007 Apr; 13(2):254-8. PubMed ID: 17378872
[TBL] [Abstract][Full Text] [Related]
16. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.
Norem CT; Schoen EJ; Walton DL; Krieger RC; O'Keefe J; To TT; Ray GT
Obstet Gynecol; 2005 Oct; 106(4):747-52. PubMed ID: 16199631
[TBL] [Abstract][Full Text] [Related]
17. alpha-Fetoprotein screening.
Burton BK
Adv Pediatr; 1986; 33():181-96. PubMed ID: 2432763
[TBL] [Abstract][Full Text] [Related]
18. Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.
Haddow JE
Semin Perinatol; 1990 Dec; 14(6):488-503. PubMed ID: 1706536
[No Abstract] [Full Text] [Related]
19. [Screening by maternal serum markers for Down's syndrome].
Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein.
Drugan A; Dvorin E; Obrien JE; Johnson MP; Evans MI
Curr Opin Obstet Gynecol; 1991 Apr; 3(2):230-4. PubMed ID: 1717020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
